Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Apr;64(4):993–1001. doi: 10.1086/302309

Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation.

T Rantamäki 1, I Kaitila 1, A C Syvänen 1, M Lukka 1, L Peltonen 1
PMCID: PMC1377823  PMID: 10090884

Abstract

Mutations in the FBN1 gene cause Marfan syndrome (MFS), a dominantly inherited connective tissue disease. Almost all the identified FBN1mutations have been family specific, and the rate of new mutations is high. We report here a de novo FBN1mutation that was identified in two sisters with MFS born to clinically unaffected parents. The paternity and maternity were unequivocally confirmed by genotyping. Although one of the parents had to be an obligatory carrier for the mutation, we could not detect the mutation in the leukocyte DNA of either parent. To identify which parent was a mosaic for the mutation we analyzed several tissues from both parents, with a quantitative and sensitive solid-phase minisequencing method. The mutation was not, however, detectable in any of the analyzed tissues. Although the mutation could not be identified in a sperm sample from the father or in samples of multiple tissue from the mother, we concluded that the mother was the likely mosaic parent and that the mutation must have occurred during the early development of her germ-line cells. Mosaicism confined to germ-line cells has rarely been reported, and this report of mosaicism for the FBN1 mutation in MFS represents an important case, in light of the evaluation of the recurrence risk in genetic counseling of families with MFS.

Full Text

The Full Text of this article is available as a PDF (318.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Budowle B., Chakraborty R., Giusti A. M., Eisenberg A. J., Allen R. C. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet. 1991 Jan;48(1):137–144. [PMC free article] [PubMed] [Google Scholar]
  2. Burgio R. G., Martini A., Cetta G., Zanaboni G., Vitellaro L., Danesino C. Asymmetric Marfan syndrome. Am J Med Genet. 1988 Aug;30(4):905–909. doi: 10.1002/ajmg.1320300405. [DOI] [PubMed] [Google Scholar]
  3. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  4. Cohn D. H., Starman B. J., Blumberg B., Byers P. H. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). Am J Hum Genet. 1990 Mar;46(3):591–601. [PMC free article] [PubMed] [Google Scholar]
  5. Collod-Béroud G., Béroud C., Ades L., Black C., Boxer M., Brock D. J., Holman K. J., de Paepe A., Francke U., Grau U. Marfan Database (third edition): new mutations and new routines for the software. Nucleic Acids Res. 1998 Jan 1;26(1):229–223. doi: 10.1093/nar/26.1.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Paepe A., Devereux R. B., Dietz H. C., Hennekam R. C., Pyeritz R. E. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996 Apr 24;62(4):417–426. doi: 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  7. Edwards M. J., Wenstrup R. J., Byers P. H., Cohn D. H. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease. Hum Mutat. 1992;1(1):47–54. doi: 10.1002/humu.1380010108. [DOI] [PubMed] [Google Scholar]
  8. Godfrey M., Olson S., Burgio R. G., Martini A., Valli M., Cetta G., Hori H., Hollister D. W. Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome. Am J Hum Genet. 1990 Apr;46(4):661–671. [PMC free article] [PubMed] [Google Scholar]
  9. Handford P. A., Mayhew M., Baron M., Winship P. R., Campbell I. D., Brownlee G. G. Key residues involved in calcium-binding motifs in EGF-like domains. Nature. 1991 May 9;351(6322):164–167. doi: 10.1038/351164a0. [DOI] [PubMed] [Google Scholar]
  10. Hewett D. R., Lynch J. R., Child A., Sykes B. C. A new missense mutation of fibrillin in a patient with Marfan syndrome. J Med Genet. 1994 Apr;31(4):338–339. doi: 10.1136/jmg.31.4.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kainulainen K., Karttunen L., Puhakka L., Sakai L., Peltonen L. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet. 1994 Jan;6(1):64–69. doi: 10.1038/ng0194-64. [DOI] [PubMed] [Google Scholar]
  12. Kainulainen K., Sakai L. Y., Child A., Pope F. M., Puhakka L., Ryhänen L., Palotie A., Kaitila I., Peltonen L. Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5917–5921. doi: 10.1073/pnas.89.13.5917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Magenis R. E., Maslen C. L., Smith L., Allen L., Sakai L. Y. Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1. Genomics. 1991 Oct;11(2):346–351. doi: 10.1016/0888-7543(91)90142-2. [DOI] [PubMed] [Google Scholar]
  14. Milewicz D. M., Grossfield J., Cao S. N., Kielty C., Covitz W., Jewett T. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest. 1995 May;95(5):2373–2378. doi: 10.1172/JCI117930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Milewicz D. M., Witz A. M., Smith A. C., Manchester D. K., Waldstein G., Byers P. H. Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring. Am J Hum Genet. 1993 Jul;53(1):62–70. [PMC free article] [PubMed] [Google Scholar]
  16. Montgomery R. A., Geraghty M. T., Bull E., Gelb B. D., Johnson M., McIntosh I., Francomano C. A., Dietz H. C. Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am J Hum Genet. 1998 Dec;63(6):1703–1711. doi: 10.1086/302144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pereira L., D'Alessio M., Ramirez F., Lynch J. R., Sykes B., Pangilinan T., Bonadio J. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet. 1993 Jul;2(7):961–968. doi: 10.1093/hmg/2.7.961. [DOI] [PubMed] [Google Scholar]
  18. Pereira L., Levran O., Ramirez F., Lynch J. R., Sykes B., Pyeritz R. E., Dietz H. C. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med. 1994 Jul 21;331(3):148–153. doi: 10.1056/NEJM199407213310302. [DOI] [PubMed] [Google Scholar]
  19. Putnam E. A., Cho M., Zinn A. B., Towbin J. A., Byers P. H., Milewicz D. M. Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet. 1996 Mar 29;62(3):233–242. doi: 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  20. Putnam E. A., Park E. S., Aalfs C. M., Hennekam R. C., Milewicz D. M. Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts. Am J Hum Genet. 1997 Apr;60(4):818–827. [PMC free article] [PubMed] [Google Scholar]
  21. Rantamäki T., Lönnqvist L., Karttunen L., Kainulainen K., Peltonen L. DNA diagnostics of the Marfan syndrome: application of amplifiable polymorphic markers. Eur J Hum Genet. 1994;2(1):66–75. doi: 10.1159/000472343. [DOI] [PubMed] [Google Scholar]
  22. Rostedt I., Lalu K., Lukka M., Sajantila A. Genotyping of five short tandem repeat loci via triplex and duplex PCR. Forensic Sci Int. 1996 Oct 25;82(3):217–226. doi: 10.1016/s0379-0738(96)02002-6. [DOI] [PubMed] [Google Scholar]
  23. Sakai L. Y., Keene D. R., Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 1986 Dec;103(6 Pt 1):2499–2509. doi: 10.1083/jcb.103.6.2499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shprintzen R. J., Goldberg R. B. A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias. J Craniofac Genet Dev Biol. 1982;2(1):65–74. [PubMed] [Google Scholar]
  25. Sood S., Eldadah Z. A., Krause W. L., McIntosh I., Dietz H. C. Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet. 1996 Feb;12(2):209–211. doi: 10.1038/ng0296-209. [DOI] [PubMed] [Google Scholar]
  26. Syvänen A. C., Aalto-Setälä K., Kontula K., Söderlund H. Direct sequencing of affinity-captured amplified human DNA application to the detection of apolipoprotein E polymorphism. FEBS Lett. 1989 Nov 20;258(1):71–74. doi: 10.1016/0014-5793(89)81618-7. [DOI] [PubMed] [Google Scholar]
  27. Syvänen A. C., Sajantila A., Lukka M. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet. 1993 Jan;52(1):46–59. [PMC free article] [PubMed] [Google Scholar]
  28. Syvänen A. C., Söderlund H., Laaksonen E., Bengtström M., Turunen M., Palotie A. N-ras gene mutations in acute myeloid leukemia: accurate detection by solid-phase minisequencing. Int J Cancer. 1992 Mar 12;50(5):713–718. doi: 10.1002/ijc.2910500508. [DOI] [PubMed] [Google Scholar]
  29. Walsh P. S., Metzger D. A., Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991 Apr;10(4):506–513. [PubMed] [Google Scholar]
  30. Wang M., Clericuzio C. L., Godfrey M. Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2. Am J Hum Genet. 1996 Nov;59(5):1027–1034. [PMC free article] [PubMed] [Google Scholar]
  31. Yates J. R., van Bakel I., Sepp T., Payne S. J., Webb D. W., Nevin N. C., Green A. J. Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. Hum Mol Genet. 1997 Dec;6(13):2265–2269. doi: 10.1093/hmg/6.13.2265. [DOI] [PubMed] [Google Scholar]
  32. Zlotogora J. Germ line mosaicism. Hum Genet. 1998 Apr;102(4):381–386. doi: 10.1007/s004390050708. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES